Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Jason Warram
Associate Professor
Close
E-mail
mojack@uab.edu
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Jason Warram
Associate Professor
Positions
Associate Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
Assistant Professor (S)
,
Radiology
,
School of Medicine
Associate Professor (P)
,
Otolaryngology
,
School of Medicine
Associate Scientist
,
Experimental Therapeutics
,
O'Neal Comprehensive Cancer Center
Scientist (C)
,
Nephrology Research & Training Center
,
General Clinical Research Center
Assistant Professor (S)
,
Surgery - General Surgery Gastrointestinal Section
,
Surgery - General Surgery
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2022
Consensus Conference Statement on the General Use of Near-infrared Fluorescence Imaging and Indocyanine Green Guided Surgery: Results of a Modified Delphi Study
.
Annals of Surgery
. 275:685-691.
2022
2022
Hyperintensity of integrin-targeted fluorescence agent IntegriSense750 accurately predicts flap necrosis compared to Indocyanine green
2022
2021
Author Correction: Positron emission tomography imaging with
89
Zr-labeled anti-CD8 cys-diabody reveals CD8
+
cell infiltration during oncolytic virus therapy in a glioma murine model (Scientific Reports, (2021), 11, 1, (15384), 10.1038/s41598-021-94887-x)
.
Scientific Reports
. 11.
2021
2021
Positron emission tomography imaging with
89
Zr-labeled anti-CD8 cys-diabody reveals CD8
+
cell infiltration during oncolytic virus therapy in a glioma murine model
.
Scientific Reports
. 11.
2021
2021
Predicting Schwannoma Growth in a Tumor Model Using Targeted Imaging
2021
2020
A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma
.
Oncogene
. 39:6961-6974.
2020
2020
Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study
.
Journal of Oral and Maxillofacial Surgery
. 78:1736-1747.
2020
2020
Comparison of panitumumab-IRDye800CW and 5-aminolevulinic acid to provide optical contrast in a model of glioblastoma multiforme
.
Molecular Cancer Therapeutics
. 19:1922-1929.
2020
2020
Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models
2020
2020
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer
.
PLoS ONE
. 15.
2020
2020
Surgical margins in oral cavity squamous cell carcinoma: Current practices and future directions
2020
2019
Fluorescence Imaging of Nerves during Surgery
.
Annals of Surgery
. 270:69-76.
2019
2019
Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer
.
Journal of Surgical Research
. 239:44-51.
2019
2019
Proceedings: Pathways for successful translation of new imaging agents and modalities—phase III studies
.
Journal of Nuclear Medicine
. 60:736-744.
2019
2019
Genetic strategy to decrease complement activation with adenoviral therapies
.
PLoS ONE
. 14.
2019
2019
Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer
*
.
Journal of Drug Targeting
. 27:193-200.
2019
2019
Current and future imaging methods for evaluating response to immunotherapy in neuro-oncology
.
Theranostics
. 9:5085-5104.
2019
2018
Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence
.
Cancer Research
. 78:5144-5154.
2018
2018
Ultrasound-Triggered Delivery of Anticancer Therapeutics from MRI-Visible Multilayer Microcapsules
.
Advanced Therapeutics
. 1.
2018
2018
Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer
.
Surgical Oncology
. 27:225-230.
2018
2018
Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma
.
Journal of Surgical Oncology
. 117:1179-1187.
2018
2018
Recommendations for reporting on emerging optical imaging agents to promote clinical approval
.
Theranostics
. 8:5336-5347.
2018
2018
Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
.
Theranostics
. 8:2488-2495.
2018
2017
Characterizing the detection threshold for optical imaging in surgical oncology
.
Journal of Surgical Oncology
. 116:898-906.
2017
2017
Fluorescence Imaging for Cancer Screening and Surveillance
2017
2017
T
1
-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery
.
Nanoscale
. 9:11785-11792.
2017
2017
Sensitivity and specificity of cetuximab-IRDye800CW to identify regional metastatic disease in head and neck cancer
.
Clinical Cancer Research
. 23:4744-4752.
2017
2017
Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation
2017
2017
Laser-assisted indocyanine green dye angiography for postoperative fistulas after salvage laryngectomy
.
JAMA Otolaryngology-Head and Neck Surgery
. 143:775-781.
2017
2017
Beyond the margins: Real-time detection of cancer using targeted fluorophores
.
Nature Reviews Clinical Oncology
. 14:347-364.
2017
2017
Regulatory aspects of optical methods and exogenous targets for cancer detection
.
Cancer Research
. 77:2197-2206.
2017
2017
Characterizing the utility and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients
.
Journal of Nuclear Medicine
. 58:246-251.
2017
2017
Effects of Neoadjuvant Chemotherapy and Radiotherapy on Flap Perfusion in a Novel Mouse Model Using Standard Clinical Assessment and Near-Infrared Fluorescence Angiography
2017
2017
Oncologic Procedures Amenable to Fluorescence-guided Surgery
.
Annals of Surgery
. 266:36-47.
2017
2017
Specimen mapping in head and neck cancer using fluorescence imaging
.
Laryngoscope Investigative Otolaryngology
. 2:447-452.
2017
2016
Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies
2016
2016
Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models
.
Cancer Medicine
. 5:1526-1534.
2016
2016
Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques
2016
2016
Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment
.
Journal of Pathology: Clinical Research
. 2:104-112.
2016
2016
On the horizon: Optical imaging for cutaneous squamous cell carcinoma
2016
2016
SPARC-independent delivery of nab-paclitaxel without depleting tumor stroma in patient-derived pancreatic Cancer xenografts
.
Molecular Cancer Therapeutics
. 15:680-688.
2016
2016
Standardized model for predicting flap failure using indocyanine green dye
.
Progress in Biomedical Optics and Imaging - Proceedings of SPIE
. 9696.
2016
2016
Successful translation of fluorescence navigation during oncologic surgery: A consensus report
.
Journal of Nuclear Medicine
. 57:144-150.
2016
2015
Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury
2015
2015
Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW
.
British Journal of Neurosurgery
. 29:850-858.
2015
2015
Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer
.
Clinical Cancer Research
. 21:3658-3666.
2015
2015
A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery
.
Journal of Surgical Oncology
. 112:2-8.
2015
2015
In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas
.
Scientific Reports
. 5.
2015
2015
IND-Directed Safety and Biodistribution Study of Intravenously Injected Cetuximab-IRDye800 in Cynomolgus Macaques
2015
2015
Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502.
.
Molecular Imaging
. 14:7290201400040.
2015
2015
Laparoscopic fluorescent visualization of the ureter with intravenous IRDye800CW
2015
2015
The status of contemporary image-guided modalities in oncologic surgery
.
Annals of Surgery
. 261:46-55.
2015
2015
Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies
.
Cancer Biology and Therapy
. 16:790-798.
2015
2014
A standardized light-emitting diode device for photoimmunotherapy
.
Journal of Nuclear Medicine
. 55:1893-1898.
2014
2014
Volumetric contrast-enhanced ultrasound imaging of renal perfusion
.
Journal of Ultrasound in Medicine
. 33:1427-1437.
2014
2014
A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging
2014
2014
Antibody-based imaging strategies for cancer
.
Cancer and Metastasis Reviews
. 33:809-822.
2014
2014
Biodistribution of P-selectin targeted microbubbles
.
Journal of Drug Targeting
. 22:387-394.
2014
2014
Breast cancer imaging using the near-infrared fluorescent agent, CLR1502
.
Molecular Imaging
. 13.
2014
2014
Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer
.
Ultrasound in Medicine and Biology
. 40:755-764.
2014
2013
Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma
2013
2013
Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy
.
IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control
. 60:281-289.
2013
2013
An Animal Model Allowing Controlled Receptor Expression for Molecular Ultrasound Imaging
.
Ultrasound in Medicine and Biology
. 39:172-180.
2013
2013
Enhancement of Adenovirus Delivery after Ultrasound-Stimulated Therapy in a Cancer Model
.
Ultrasound in Medicine and Biology
. 39:2374-2381.
2013
2012
Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles
.
Cancer Gene Therapy
. 19:545-552.
2012
2012
Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma
2012
2012
Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer
.
Journal of Drug Targeting
. 20:43-54.
2012
2011
Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells
2011
2011
Model System Using Controlled Receptor Expression for Evaluating Targeted Ultrasound Contrast Agents
.
Ultrasound in Medicine and Biology
. 37:1306-1313.
2011
2011
A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature
.
Journal of Ultrasound in Medicine
. 30:921-931.
2011
2011
A genetic strategy for combined screening and localized imaging of breast cancer
2011
2010
Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks
.
Journal of Ultrasound in Medicine
. 29:577-585.
2010
2009
Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis
.
Cancer Biology and Therapy
. 8:1109-1116.
2009
2008
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenograftsby diffusion-weighted magnetic resonance imaging
.
Cancer Research
. 68:8369-8376.
2008
2008
Breast tumor xenografts: Diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody
.
Radiology
. 248:844-851.
2008
2008
Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: A novel mechanism for GH insensitivity
2008
Chapter
Filter
Year
Title
Altmetric
2015
Translation of therapeutic antibodies for intraoperative fluorescence imaging
. 25-33.
2015
Research
Principal Investigator On
Dual PET/Fluorescence Imaging of Glioma with an MMP-14 Activabable Peptide Probe
awarded by
DOD - Department of Defense
Imaging Guided Surgery Using Fluorescently Labeled Cetuximab
awarded by
National Cancer Institute/NIH/DHHS
Private Grant
awarded by
LICOR, INC.
Private Grant
awarded by
LICOR, INC.
Private Grant
awarded by
LICOR, INC.
Private Grant
awarded by
NOVADAQ TECHNOLOGIES, INC.
Private Grant
awarded by
LICOR, INC.
Reduction of Tumor-Positive Margins in Oncology Surgery
awarded by
National Cancer Institute/NIH/DHHS
Investigator On
A Specific Screening Strategy to Reduce Prostate Cancer Mortality
awarded by
DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
Comprehensive Cancer Center Core Support Grant
awarded by
National Cancer Institute/NIH/DHHS
Comprehensive Cancer Center Core Support Grant
awarded by
National Cancer Institute/NIH/DHHS
Comprehensive Cancer Center Core Support Grant
awarded by
National Cancer Institute/NIH/DHHS
Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
awarded by
National Cancer Institute/NIH/DHHS
Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility
awarded by
National Cancer Institute/NIH/DHHS
Imaging Guided Surgery using Fluorescently Labeled Cetuximab
awarded by
National Cancer Institute/NIH/DHHS
Lumina III System for UAB Optical Imaging
awarded by
NIH - OFFICE OF THE DIRECTOR
Non-Invasive Imaging of Ameloblastomas
awarded by
National Institute of Dental and Craniofacial Research/NIH/DHHS
Phase 1, Open-Label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer during Surgical Procedures
awarded by
Stanford University
Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
awarded by
Stanford University
Private Grant
awarded by
LICOR, INC.
Private Grant
awarded by
CYTOSITE BIOPHARMA INC
Research Training Program in Surgical Oncology
awarded by
National Cancer Institute/NIH/DHHS
UAB-UCSD O'Brien Center for Acute Kidney Injury Research
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
UAB-UCSD O'Brien Center for Acute Kidney Injury Research - Core B
awarded by
National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
Background
Education And Training
Doctor of Philosophy in Physiology, Pathology and Related Sciences,
University of Alabama at Birmingham
2011
Bachelor of Science or Mathematics,
University of Alabama at Birmingham
2002
Contact
Full Name
Jason
Warram